A portion of people who had applied to enroll for AIIMS coronavirus vaccine trial for India’s first indigenous vaccine, Covaxin have already developed antibodies against the novel coronavirus. The sources at AIIMS said that about 20% of the enrolled people in trial have thus been rendered unfit for the trial. It has been two weeks ...

The trials of the world’s first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University have been effectively completed. Elena Smolyarchuk, the chief researcher at the university, told Tass news on Sunday that the research and the final results of the vaccine came out effective. In the month of March, the World Health Organization (WHO) ...